Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025
Anika Therapeutics (NASDAQ: ANIK), a global joint preservation company specializing in early intervention orthopedics, has scheduled the release of its first quarter 2025 financial results before market opening on Friday, May 9, 2025.
The company will host a conference call at 8:30 a.m. ET to discuss the results and business highlights. Investors can join via phone using toll-free domestic (1-800-717-1738) or international (1-646-307-1865) numbers with conference ID 63463. A live audio webcast with presentation materials will be available on Anika's website investor relations section.
Anika Therapeutics (NASDAQ: ANIK), un'azienda globale specializzata nella preservazione articolare e nelle ortopedie a intervento precoce, ha programmato la pubblicazione dei suoi risultati finanziari del primo trimestre 2025 prima dell'apertura dei mercati di venerdì 9 maggio 2025.
L'azienda terrà una conference call alle 8:30 a.m. ET per discutere i risultati e i principali sviluppi aziendali. Gli investitori potranno partecipare telefonicamente utilizzando i numeri verdi nazionali (1-800-717-1738) o internazionali (1-646-307-1865) con ID conferenza 63463. Una diretta audio webcast con materiali di presentazione sarà disponibile nella sezione relazioni con gli investitori del sito web di Anika.
Anika Therapeutics (NASDAQ: ANIK), una empresa global especializada en la preservación articular y ortopedia de intervención temprana, ha programado la publicación de sus resultados financieros del primer trimestre de 2025 antes de la apertura del mercado el viernes 9 de mayo de 2025.
La compañía realizará una llamada conferencia a las 8:30 a.m. ET para comentar los resultados y los aspectos destacados del negocio. Los inversores podrán unirse por teléfono usando números gratuitos nacionales (1-800-717-1738) o internacionales (1-646-307-1865) con ID de conferencia 63463. Habrá una retransmisión de audio en vivo con materiales de presentación disponible en la sección de relaciones con inversores del sitio web de Anika.
Anika Therapeutics (NASDAQ: ANIK)는 조기 개입 정형외과에 특화된 글로벌 관절 보존 회사로, 2025년 1분기 재무 실적을 2025년 5월 9일 금요일 시장 개장 전 발표할 예정입니다.
회사는 오전 8:30 ET에 실적 및 사업 주요 내용을 논의하는 컨퍼런스 콜을 진행합니다. 투자자들은 국내 무료 전화(1-800-717-1738) 또는 국제 전화(1-646-307-1865)를 통해 회의 ID 63463로 참여할 수 있습니다. 발표 자료와 함께 실시간 오디오 웹캐스트가 Anika 웹사이트 투자자 관계 섹션에서 제공됩니다.
Anika Therapeutics (NASDAQ : ANIK), une entreprise mondiale spécialisée dans la préservation articulaire et l’orthopédie interventionnelle précoce, a prévu de publier ses résultats financiers du premier trimestre 2025 avant l’ouverture des marchés, le vendredi 9 mai 2025.
La société tiendra une conférence téléphonique à 8h30 ET pour discuter des résultats et des faits marquants de l’activité. Les investisseurs pourront participer par téléphone en utilisant les numéros gratuits nationaux (1-800-717-1738) ou internationaux (1-646-307-1865) avec l’identifiant de conférence 63463. Un webcast audio en direct avec les supports de présentation sera disponible dans la section relations investisseurs du site web d’Anika.
Anika Therapeutics (NASDAQ: ANIK), ein weltweit tätiges Unternehmen für Gelenkerhalt mit Spezialisierung auf frühzeitige orthopädische Interventionen, hat die Veröffentlichung seiner Finanzergebnisse für das erste Quartal 2025 vor Börsenbeginn am Freitag, den 9. Mai 2025, angekündigt.
Das Unternehmen wird um 8:30 Uhr ET eine Telefonkonferenz abhalten, um die Ergebnisse und geschäftlichen Highlights zu besprechen. Investoren können über gebührenfreie nationale (1-800-717-1738) oder internationale (1-646-307-1865) Telefonnummern mit der Konferenz-ID 63463 teilnehmen. Ein Live-Audio-Webcast mit Präsentationsmaterialien wird im Investor-Relations-Bereich der Anika-Website verfügbar sein.
- None.
- None.
BEDFORD, Mass., April 25, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its first quarter 2025 financial results before the opening of the market on Friday, May 9, 2025, followed by a conference call at 8:30 a.m. ET to discuss its results and business highlights.
The conference call can be accessed by dialing 1-800-717-1738 (toll-free domestic) or 1-646-307-1865 (international) and providing the conference ID number 63463. A live audio webcast and accompanying presentation materials will be available in the Investor Relations section of Anika's website, www.anika.com. The call will be archived and accessible on the same website shortly after its conclusion.
About Anika
Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Leveraging our core expertise in hyaluronic acid and implant solutions, we partner with clinicians to provide minimally invasive products that restore active living for people around the world. Our focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management and Regenerative Solutions, and our products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika’s global operations are headquartered outside of Boston, Massachusetts. For more information about Anika, please visit www.anika.com.
ANIKA, ANIKA THERAPEUTICS and the Anika logo are trademarks of Anika Therapeutics, Inc. or its subsidiaries or are licensed to Anika Therapeutics, Inc. for its use.
For Investor Inquiries:
Anika Therapeutics, Inc.
Matt Hall, 781-457-9554
Director, Corporate Development and Investor Relations
investorrelations@anika.com
FAQ
When will Anika Therapeutics (ANIK) release Q1 2025 earnings?
How can investors access ANIK's Q1 2025 earnings call?
What time is Anika Therapeutics' Q1 2025 earnings conference call?
Where can I find ANIK's Q1 2025 earnings presentation materials?
